

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 6.52551829 |
| 2 | protein maturation by protein folding (GO:0022417) | 5.35889719 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 5.17883003 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 5.17883003 |
| 5 | formation of translation preinitiation complex (GO:0001731) | 4.71491523 |
| 6 | proteasome assembly (GO:0043248) | 4.51850688 |
| 7 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.94774717 |
| 8 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.89383222 |
| 9 | ribosomal small subunit assembly (GO:0000028) | 3.85713649 |
| 10 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.85479080 |
| 11 | viral transcription (GO:0019083) | 3.67691825 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.65451564 |
| 13 | ribosomal small subunit biogenesis (GO:0042274) | 3.64522815 |
| 14 | negative regulation of ligase activity (GO:0051352) | 3.63391793 |
| 15 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.63391793 |
| 16 | maturation of SSU-rRNA (GO:0030490) | 3.62135942 |
| 17 | DNA strand elongation (GO:0022616) | 3.62015961 |
| 18 | chaperone-mediated protein transport (GO:0072321) | 3.61456869 |
| 19 | regulation of mitochondrial translation (GO:0070129) | 3.61196899 |
| 20 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.61067573 |
| 21 | negative regulation of B cell apoptotic process (GO:0002903) | 3.58816852 |
| 22 | translational termination (GO:0006415) | 3.56671947 |
| 23 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.56613991 |
| 24 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.50777457 |
| 25 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.50103387 |
| 26 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.49076184 |
| 27 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.47851617 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.47756494 |
| 29 | amino acid salvage (GO:0043102) | 3.46464763 |
| 30 | L-methionine salvage (GO:0071267) | 3.46464763 |
| 31 | L-methionine biosynthetic process (GO:0071265) | 3.46464763 |
| 32 | translational elongation (GO:0006414) | 3.45835990 |
| 33 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.44554651 |
| 34 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.44554651 |
| 35 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.41863597 |
| 36 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.41863597 |
| 37 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.41863597 |
| 38 | translational initiation (GO:0006413) | 3.40138425 |
| 39 | nucleobase biosynthetic process (GO:0046112) | 3.39906263 |
| 40 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.39365489 |
| 41 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.39365489 |
| 42 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.37565408 |
| 43 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.36436447 |
| 44 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.35359205 |
| 45 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.34495382 |
| 46 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.34495382 |
| 47 | folic acid metabolic process (GO:0046655) | 3.34126201 |
| 48 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.32585385 |
| 49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.32585385 |
| 50 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.31700980 |
| 51 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.31120000 |
| 52 | ribosome biogenesis (GO:0042254) | 3.30736657 |
| 53 | cotranslational protein targeting to membrane (GO:0006613) | 3.29856195 |
| 54 | pseudouridine synthesis (GO:0001522) | 3.27941639 |
| 55 | protein targeting to ER (GO:0045047) | 3.27322948 |
| 56 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.26387735 |
| 57 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.22582969 |
| 58 | mitotic nuclear envelope reassembly (GO:0007084) | 3.20909367 |
| 59 | nuclear envelope reassembly (GO:0031468) | 3.20909367 |
| 60 | protein localization to endoplasmic reticulum (GO:0070972) | 3.18387838 |
| 61 | ribosome assembly (GO:0042255) | 3.17240362 |
| 62 | translation (GO:0006412) | 3.13692109 |
| 63 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.13515522 |
| 64 | ATP synthesis coupled proton transport (GO:0015986) | 3.13515522 |
| 65 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.13196376 |
| 66 | DNA replication initiation (GO:0006270) | 3.13119321 |
| 67 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.13117432 |
| 68 | protein deneddylation (GO:0000338) | 3.12647559 |
| 69 | purine nucleobase biosynthetic process (GO:0009113) | 3.11777900 |
| 70 | regulation of cellular amine metabolic process (GO:0033238) | 3.11057449 |
| 71 | nucleotide salvage (GO:0043173) | 3.10785940 |
| 72 | protein localization to mitochondrion (GO:0070585) | 3.10499673 |
| 73 | NADH metabolic process (GO:0006734) | 3.08909388 |
| 74 | protein retention in ER lumen (GO:0006621) | 3.08002245 |
| 75 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.07950711 |
| 76 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.07364313 |
| 77 | oxidative phosphorylation (GO:0006119) | 3.07111993 |
| 78 | mannosylation (GO:0097502) | 3.06577662 |
| 79 | positive regulation of ligase activity (GO:0051351) | 3.04323313 |
| 80 | telomere maintenance via recombination (GO:0000722) | 3.03614898 |
| 81 | GTP biosynthetic process (GO:0006183) | 3.01686832 |
| 82 | purine nucleotide salvage (GO:0032261) | 3.00381415 |
| 83 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.99378980 |
| 84 | pentose metabolic process (GO:0019321) | 2.98117206 |
| 85 | base-excision repair, AP site formation (GO:0006285) | 2.97054670 |
| 86 | DNA replication checkpoint (GO:0000076) | 2.95773212 |
| 87 | regulation of protein heterodimerization activity (GO:0043497) | 2.95621911 |
| 88 | proline biosynthetic process (GO:0006561) | 2.95239412 |
| 89 | UTP biosynthetic process (GO:0006228) | 2.94721156 |
| 90 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.94073772 |
| 91 | positive regulation of cell cycle arrest (GO:0071158) | 2.92091988 |
| 92 | rRNA processing (GO:0006364) | 2.91990759 |
| 93 | viral life cycle (GO:0019058) | 2.91871022 |
| 94 | protein complex biogenesis (GO:0070271) | 2.91273204 |
| 95 | respiratory electron transport chain (GO:0022904) | 2.90565293 |
| 96 | GDP-mannose metabolic process (GO:0019673) | 2.89753563 |
| 97 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.89168204 |
| 98 | tRNA aminoacylation for protein translation (GO:0006418) | 2.87561917 |
| 99 | ribosomal large subunit biogenesis (GO:0042273) | 2.85545200 |
| 100 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.85393388 |
| 101 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.85110655 |
| 102 | cullin deneddylation (GO:0010388) | 2.84237269 |
| 103 | electron transport chain (GO:0022900) | 2.83789097 |
| 104 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.83111221 |
| 105 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.82140388 |
| 106 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.81558140 |
| 107 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.81311686 |
| 108 | tricarboxylic acid cycle (GO:0006099) | 2.79432730 |
| 109 | rRNA metabolic process (GO:0016072) | 2.79067314 |
| 110 | DNA unwinding involved in DNA replication (GO:0006268) | 2.78361636 |
| 111 | CTP metabolic process (GO:0046036) | 2.78025141 |
| 112 | CTP biosynthetic process (GO:0006241) | 2.78025141 |
| 113 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.77643901 |
| 114 | tRNA aminoacylation (GO:0043039) | 2.77526701 |
| 115 | amino acid activation (GO:0043038) | 2.77526701 |
| 116 | sequestering of actin monomers (GO:0042989) | 2.76879999 |
| 117 | cellular protein complex disassembly (GO:0043624) | 2.76735637 |
| 118 | heme metabolic process (GO:0042168) | 2.76506446 |
| 119 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.76375693 |
| 120 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.75899887 |
| 121 | telomere maintenance via telomere lengthening (GO:0010833) | 2.75601839 |
| 122 | negative regulation of protein ubiquitination (GO:0031397) | 2.75492761 |
| 123 | spliceosomal snRNP assembly (GO:0000387) | 2.75320473 |
| 124 | regulation of ligase activity (GO:0051340) | 2.75255439 |
| 125 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.74308914 |
| 126 | heme biosynthetic process (GO:0006783) | 2.74169744 |
| 127 | termination of RNA polymerase III transcription (GO:0006386) | 2.73741261 |
| 128 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.73741261 |
| 129 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.73234340 |
| 130 | peptidyl-histidine modification (GO:0018202) | 2.72925512 |
| 131 | cell cycle G1/S phase transition (GO:0044843) | 2.72572229 |
| 132 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.72572229 |
| 133 | rRNA modification (GO:0000154) | 2.71191021 |
| 134 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.70457288 |
| 135 | melanin biosynthetic process (GO:0042438) | 2.68350346 |
| 136 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.67784398 |
| 137 | NADH dehydrogenase complex assembly (GO:0010257) | 2.67662830 |
| 138 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.67662830 |
| 139 | methionine biosynthetic process (GO:0009086) | 2.67548635 |
| 140 | nucleoside salvage (GO:0043174) | 2.66632565 |
| 141 | cellular component biogenesis (GO:0044085) | 2.64380551 |
| 142 | iron-sulfur cluster assembly (GO:0016226) | 2.64025861 |
| 143 | metallo-sulfur cluster assembly (GO:0031163) | 2.64025861 |
| 144 | establishment of protein localization to mitochondrion (GO:0072655) | 2.61651518 |
| 145 | pentose-phosphate shunt (GO:0006098) | 2.60613089 |
| 146 | protein targeting to mitochondrion (GO:0006626) | 2.60551310 |
| 147 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.59712656 |
| 148 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.59611792 |
| 149 | IMP biosynthetic process (GO:0006188) | 2.59175386 |
| 150 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.58199428 |
| 151 | regulation of cell cycle arrest (GO:0071156) | 2.57698243 |
| 152 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.56424404 |
| 153 | folic acid transport (GO:0015884) | 2.55624654 |
| 154 | mitotic recombination (GO:0006312) | 2.54783523 |
| 155 | galactose catabolic process (GO:0019388) | 2.52556098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.20593689 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.94486330 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.50334994 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.13834233 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.05842392 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.86070238 |
| 7 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.81091664 |
| 8 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.71928997 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.70865783 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.70323053 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.37871723 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.31506172 |
| 13 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.29110581 |
| 14 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.26791463 |
| 15 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.16999943 |
| 16 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.11889858 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.10190419 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.08689019 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 1.97083315 |
| 20 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.94695661 |
| 21 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.91538383 |
| 22 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.90838491 |
| 23 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.89576929 |
| 24 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88050982 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.87935597 |
| 26 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81340711 |
| 27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.79679941 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.79471885 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.78555686 |
| 30 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.77545699 |
| 31 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.77128391 |
| 32 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.68433829 |
| 33 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.66976976 |
| 34 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.66166142 |
| 35 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.61911618 |
| 36 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.58423006 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.53193454 |
| 38 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.51789955 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51671831 |
| 40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.49982447 |
| 41 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48204747 |
| 42 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.46288246 |
| 43 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.43161339 |
| 44 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.41995141 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.41310795 |
| 46 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.39917520 |
| 47 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.39186821 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.37931360 |
| 49 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.37600561 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.36759339 |
| 51 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.35939358 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.35783871 |
| 53 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.35190215 |
| 54 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35039343 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.34922224 |
| 56 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.33373275 |
| 57 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.33149947 |
| 58 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.31947490 |
| 59 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.31863719 |
| 60 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31675747 |
| 61 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.31210014 |
| 62 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.30953358 |
| 63 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.30511961 |
| 64 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.29412368 |
| 65 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.28401935 |
| 66 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27029909 |
| 67 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.24808450 |
| 68 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.24704340 |
| 69 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.23408521 |
| 70 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.22986388 |
| 71 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22142560 |
| 72 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.21580480 |
| 73 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20417238 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 1.20285517 |
| 75 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19011880 |
| 76 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.18575667 |
| 77 | MAF_26560356_Chip-Seq_TH1_Human | 1.17032169 |
| 78 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.16947050 |
| 79 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.16245879 |
| 80 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.16095468 |
| 81 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.16048877 |
| 82 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.15796968 |
| 83 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.15770759 |
| 84 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14291105 |
| 85 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.14240376 |
| 86 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.14116258 |
| 87 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.13971492 |
| 88 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.13927616 |
| 89 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.13571093 |
| 90 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13418027 |
| 91 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.13223816 |
| 92 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13174766 |
| 93 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.12426402 |
| 94 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.11988603 |
| 95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11730735 |
| 96 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.11523315 |
| 97 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11437057 |
| 98 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11293224 |
| 99 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09646719 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09581878 |
| 101 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.09543256 |
| 102 | MAF_26560356_Chip-Seq_TH2_Human | 1.09253072 |
| 103 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09206171 |
| 104 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08760725 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07856871 |
| 106 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.06143283 |
| 107 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.05382973 |
| 108 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05371812 |
| 109 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.05105231 |
| 110 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.04889790 |
| 111 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.02928999 |
| 112 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02410103 |
| 113 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.99605363 |
| 114 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99476516 |
| 115 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99460988 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99031978 |
| 117 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98295454 |
| 118 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.98045391 |
| 119 | MYB_26560356_Chip-Seq_TH2_Human | 0.97819666 |
| 120 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95335064 |
| 121 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95090808 |
| 122 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93595721 |
| 123 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93248561 |
| 124 | MYB_26560356_Chip-Seq_TH1_Human | 0.92988154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.61945499 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.47980273 |
| 3 | MP0000372_irregular_coat_pigmentation | 3.36533422 |
| 4 | MP0005171_absent_coat_pigmentation | 3.24858856 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 3.00451088 |
| 6 | MP0003763_abnormal_thymus_physiology | 2.86073125 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 2.79839584 |
| 8 | MP0009840_abnormal_foam_cell | 2.70772600 |
| 9 | MP0009333_abnormal_splenocyte_physiolog | 2.69796235 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.65894943 |
| 11 | MP0003111_abnormal_nucleus_morphology | 2.42937912 |
| 12 | MP0005671_abnormal_response_to | 2.27399282 |
| 13 | MP0005408_hypopigmentation | 2.21909396 |
| 14 | MP0003077_abnormal_cell_cycle | 2.19143363 |
| 15 | MP0003186_abnormal_redox_activity | 2.11019447 |
| 16 | MP0010094_abnormal_chromosome_stability | 2.07269546 |
| 17 | MP0000685_abnormal_immune_system | 2.05227153 |
| 18 | MP0009785_altered_susceptibility_to | 1.94966744 |
| 19 | MP0005058_abnormal_lysosome_morphology | 1.94573131 |
| 20 | MP0000689_abnormal_spleen_morphology | 1.85886911 |
| 21 | MP0002398_abnormal_bone_marrow | 1.84954358 |
| 22 | MP0003436_decreased_susceptibility_to | 1.84855308 |
| 23 | MP0002722_abnormal_immune_system | 1.81746916 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 1.80214313 |
| 25 | MP0000490_abnormal_crypts_of | 1.80059158 |
| 26 | MP0000858_altered_metastatic_potential | 1.79416742 |
| 27 | MP0003724_increased_susceptibility_to | 1.74168234 |
| 28 | MP0001545_abnormal_hematopoietic_system | 1.73747249 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 1.73747249 |
| 30 | MP0001661_extended_life_span | 1.71934655 |
| 31 | MP0005025_abnormal_response_to | 1.66422644 |
| 32 | MP0001835_abnormal_antigen_presentation | 1.66414612 |
| 33 | MP0000015_abnormal_ear_pigmentation | 1.59415389 |
| 34 | MP0000751_myopathy | 1.59068004 |
| 35 | MP0001853_heart_inflammation | 1.58867653 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.57881745 |
| 37 | MP0000716_abnormal_immune_system | 1.57596864 |
| 38 | MP0001819_abnormal_immune_cell | 1.55692946 |
| 39 | MP0001800_abnormal_humoral_immune | 1.55615379 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.54691230 |
| 41 | MP0008057_abnormal_DNA_replication | 1.54442125 |
| 42 | MP0002405_respiratory_system_inflammati | 1.54269840 |
| 43 | MP0002429_abnormal_blood_cell | 1.54210540 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.54144751 |
| 45 | MP0005023_abnormal_wound_healing | 1.53946095 |
| 46 | MP0000604_amyloidosis | 1.53208990 |
| 47 | MP0002723_abnormal_immune_serum | 1.52068938 |
| 48 | MP0008932_abnormal_embryonic_tissue | 1.51852529 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.51560138 |
| 50 | MP0008007_abnormal_cellular_replicative | 1.49163832 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.48094535 |
| 52 | MP0002019_abnormal_tumor_incidence | 1.46900654 |
| 53 | MP0010352_gastrointestinal_tract_polyps | 1.43843061 |
| 54 | MP0008058_abnormal_DNA_repair | 1.43601355 |
| 55 | MP0006082_CNS_inflammation | 1.42386432 |
| 56 | MP0000358_abnormal_cell_content/ | 1.41014986 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.40745048 |
| 58 | MP0001730_embryonic_growth_arrest | 1.40111871 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.38728498 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.38723499 |
| 61 | MP0004233_abnormal_muscle_weight | 1.38364356 |
| 62 | MP0008875_abnormal_xenobiotic_pharmacok | 1.36846088 |
| 63 | MP0005670_abnormal_white_adipose | 1.35492527 |
| 64 | MP0002132_abnormal_respiratory_system | 1.34208018 |
| 65 | MP0002419_abnormal_innate_immunity | 1.29794328 |
| 66 | MP0005451_abnormal_body_composition | 1.27036930 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.26245125 |
| 68 | MP0004381_abnormal_hair_follicle | 1.24899508 |
| 69 | MP0003786_premature_aging | 1.23394052 |
| 70 | MP0005387_immune_system_phenotype | 1.21268347 |
| 71 | MP0001790_abnormal_immune_system | 1.21268347 |
| 72 | MP0000350_abnormal_cell_proliferation | 1.20726155 |
| 73 | MP0005083_abnormal_biliary_tract | 1.20521282 |
| 74 | MP0002933_joint_inflammation | 1.18907565 |
| 75 | MP0005165_increased_susceptibility_to | 1.16678125 |
| 76 | MP0006054_spinal_hemorrhage | 1.16623812 |
| 77 | MP0004808_abnormal_hematopoietic_stem | 1.14840047 |
| 78 | MP0008469_abnormal_protein_level | 1.14784841 |
| 79 | MP0001845_abnormal_inflammatory_respons | 1.14183462 |
| 80 | MP0002166_altered_tumor_susceptibility | 1.13790595 |
| 81 | MP0002139_abnormal_hepatobiliary_system | 1.13775465 |
| 82 | MP0005501_abnormal_skin_physiology | 1.12301699 |
| 83 | MP0000313_abnormal_cell_death | 1.11767404 |
| 84 | MP0004147_increased_porphyrin_level | 1.11577513 |
| 85 | MP0001533_abnormal_skeleton_physiology | 1.10799683 |
| 86 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09505723 |
| 87 | MP0001727_abnormal_embryo_implantation | 1.09018362 |
| 88 | MP0010155_abnormal_intestine_physiology | 1.08375235 |
| 89 | MP0003279_aneurysm | 1.05082319 |
| 90 | MP0003566_abnormal_cell_adhesion | 1.03316190 |
| 91 | MP0002080_prenatal_lethality | 1.03010867 |
| 92 | MP0003329_amyloid_beta_deposits | 1.02455853 |
| 93 | MP0001542_abnormal_bone_strength | 1.01313410 |
| 94 | MP0001764_abnormal_homeostasis | 1.00795117 |
| 95 | MP0005174_abnormal_tail_pigmentation | 1.00659449 |
| 96 | MP0000343_altered_response_to | 1.00424248 |
| 97 | MP0004858_abnormal_nervous_system | 1.00068018 |
| 98 | MP0000749_muscle_degeneration | 0.99810124 |
| 99 | MP0001905_abnormal_dopamine_level | 0.99459754 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.97324439 |
| 101 | MP0000598_abnormal_liver_morphology | 0.96998913 |
| 102 | MP0002269_muscular_atrophy | 0.96835344 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.95723263 |
| 104 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95384614 |
| 105 | MP0001881_abnormal_mammary_gland | 0.94322696 |
| 106 | MP0008438_abnormal_cutaneous_collagen | 0.91532823 |
| 107 | MP0001697_abnormal_embryo_size | 0.90833248 |
| 108 | MP0001873_stomach_inflammation | 0.90792997 |
| 109 | MP0008260_abnormal_autophagy | 0.90751943 |
| 110 | MP0003448_altered_tumor_morphology | 0.90308084 |
| 111 | MP0004947_skin_inflammation | 0.89898891 |
| 112 | MP0003075_altered_response_to | 0.89815235 |
| 113 | MP0000750_abnormal_muscle_regeneration | 0.88806347 |
| 114 | MP0002060_abnormal_skin_morphology | 0.88566587 |
| 115 | MP0009697_abnormal_copulation | 0.88551475 |
| 116 | MP0002148_abnormal_hypersensitivity_rea | 0.88403823 |
| 117 | MP0003866_abnormal_defecation | 0.88044085 |
| 118 | MP0009643_abnormal_urine_homeostasis | 0.87935901 |
| 119 | MP0005332_abnormal_amino_acid | 0.86744402 |
| 120 | MP0005330_cardiomyopathy | 0.85453968 |
| 121 | MP0001243_abnormal_dermal_layer | 0.85393427 |
| 122 | MP0002006_tumorigenesis | 0.84675484 |
| 123 | MP0005623_abnormal_meninges_morphology | 0.84386241 |
| 124 | MP0003136_yellow_coat_color | 0.84116213 |
| 125 | MP0005360_urolithiasis | 0.83232341 |
| 126 | MP0000681_abnormal_thyroid_gland | 0.82930997 |
| 127 | MP0000371_diluted_coat_color | 0.82844075 |
| 128 | MP0002089_abnormal_postnatal_growth/wei | 0.81517525 |
| 129 | MP0005266_abnormal_metabolism | 0.81265894 |
| 130 | MP0000465_gastrointestinal_hemorrhage | 0.79629366 |
| 131 | MP0000609_abnormal_liver_physiology | 0.79268233 |
| 132 | MP0000747_muscle_weakness | 0.76054295 |
| 133 | MP0000003_abnormal_adipose_tissue | 0.73759453 |
| 134 | MP0005257_abnormal_intraocular_pressure | 0.71530157 |
| 135 | MP0000678_abnormal_parathyroid_gland | 0.71469404 |
| 136 | MP0001529_abnormal_vocalization | 0.71274424 |
| 137 | MP0001186_pigmentation_phenotype | 0.69240197 |
| 138 | MP0002095_abnormal_skin_pigmentation | 0.69061356 |
| 139 | MP0000759_abnormal_skeletal_muscle | 0.67170951 |
| 140 | MP0005384_cellular_phenotype | 0.66330482 |
| 141 | MP0003718_maternal_effect | 0.65451924 |
| 142 | MP0000013_abnormal_adipose_tissue | 0.65223148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.01317115 |
| 2 | Cholecystitis (HP:0001082) | 3.87353714 |
| 3 | Abnormal gallbladder physiology (HP:0012438) | 3.87353714 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 3.73098950 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 3.63000586 |
| 6 | Cerebral hypomyelination (HP:0006808) | 3.56914708 |
| 7 | Acute encephalopathy (HP:0006846) | 3.49914829 |
| 8 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.48213750 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.38443968 |
| 10 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.33596024 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.33596024 |
| 12 | Multiple enchondromatosis (HP:0005701) | 3.14626566 |
| 13 | Testicular atrophy (HP:0000029) | 3.12181827 |
| 14 | Petechiae (HP:0000967) | 3.11455249 |
| 15 | Microvesicular hepatic steatosis (HP:0001414) | 3.09275603 |
| 16 | Hepatic necrosis (HP:0002605) | 3.06679467 |
| 17 | Degeneration of anterior horn cells (HP:0002398) | 3.05419486 |
| 18 | Abnormality of the anterior horn cell (HP:0006802) | 3.05419486 |
| 19 | Hepatocellular necrosis (HP:0001404) | 3.03659397 |
| 20 | Oral leukoplakia (HP:0002745) | 3.01435745 |
| 21 | Exercise intolerance (HP:0003546) | 2.94635361 |
| 22 | Renal Fanconi syndrome (HP:0001994) | 2.94476648 |
| 23 | Spastic paraparesis (HP:0002313) | 2.85332057 |
| 24 | Combined immunodeficiency (HP:0005387) | 2.83861440 |
| 25 | Hypokinesia (HP:0002375) | 2.82456475 |
| 26 | Increased hepatocellular lipid droplets (HP:0006565) | 2.79495360 |
| 27 | IgM deficiency (HP:0002850) | 2.78976590 |
| 28 | Progressive macrocephaly (HP:0004481) | 2.76144285 |
| 29 | Lipid accumulation in hepatocytes (HP:0006561) | 2.67952056 |
| 30 | Rough bone trabeculation (HP:0100670) | 2.67309902 |
| 31 | Trismus (HP:0000211) | 2.66117161 |
| 32 | Aplastic anemia (HP:0001915) | 2.63857727 |
| 33 | Type I transferrin isoform profile (HP:0003642) | 2.62320628 |
| 34 | Severe combined immunodeficiency (HP:0004430) | 2.60113978 |
| 35 | T lymphocytopenia (HP:0005403) | 2.57553616 |
| 36 | Thrombocytosis (HP:0001894) | 2.54856517 |
| 37 | Cerebral edema (HP:0002181) | 2.54815658 |
| 38 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.54434788 |
| 39 | Increased serum lactate (HP:0002151) | 2.52366045 |
| 40 | Increased serum ferritin (HP:0003281) | 2.49295657 |
| 41 | Reticulocytopenia (HP:0001896) | 2.48800010 |
| 42 | Vertebral compression fractures (HP:0002953) | 2.48529961 |
| 43 | Poor head control (HP:0002421) | 2.45374511 |
| 44 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.45001243 |
| 45 | Pustule (HP:0200039) | 2.43041599 |
| 46 | Abnormality of T cell number (HP:0011839) | 2.41932631 |
| 47 | Respiratory failure (HP:0002878) | 2.40803892 |
| 48 | Cholelithiasis (HP:0001081) | 2.39876527 |
| 49 | Reduced antithrombin III activity (HP:0001976) | 2.38960984 |
| 50 | Neoplasm of head and neck (HP:0012288) | 2.38101097 |
| 51 | Esophageal neoplasm (HP:0100751) | 2.38101097 |
| 52 | Microretrognathia (HP:0000308) | 2.34686047 |
| 53 | Upper limb muscle weakness (HP:0003484) | 2.32285222 |
| 54 | Abnormality of T cells (HP:0002843) | 2.27657750 |
| 55 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.25991910 |
| 56 | Abnormal gallbladder morphology (HP:0012437) | 2.25482572 |
| 57 | Birth length less than 3rd percentile (HP:0003561) | 2.24673150 |
| 58 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.24122437 |
| 59 | Breast hypoplasia (HP:0003187) | 2.23537747 |
| 60 | Recurrent bronchitis (HP:0002837) | 2.23165794 |
| 61 | Vacuolated lymphocytes (HP:0001922) | 2.22671822 |
| 62 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.22313888 |
| 63 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.22313888 |
| 64 | Abnormal protein glycosylation (HP:0012346) | 2.22313888 |
| 65 | Abnormal glycosylation (HP:0012345) | 2.22313888 |
| 66 | Abnormality of the umbilical cord (HP:0010881) | 2.21315235 |
| 67 | Macrocytic anemia (HP:0001972) | 2.21293808 |
| 68 | Carpal bone hypoplasia (HP:0001498) | 2.19408285 |
| 69 | Chronic otitis media (HP:0000389) | 2.19359438 |
| 70 | CNS demyelination (HP:0007305) | 2.18606450 |
| 71 | Rhabdomyolysis (HP:0003201) | 2.18143832 |
| 72 | Mitochondrial inheritance (HP:0001427) | 2.18076237 |
| 73 | Prolonged neonatal jaundice (HP:0006579) | 2.17713199 |
| 74 | Patchy hypopigmentation of hair (HP:0011365) | 2.15884993 |
| 75 | Entropion (HP:0000621) | 2.15726954 |
| 76 | Beaking of vertebral bodies (HP:0004568) | 2.15256273 |
| 77 | Emotional lability (HP:0000712) | 2.14931384 |
| 78 | Premature ovarian failure (HP:0008209) | 2.14697157 |
| 79 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.14496247 |
| 80 | Purpura (HP:0000979) | 2.13913954 |
| 81 | Increased muscle lipid content (HP:0009058) | 2.13365077 |
| 82 | Muscle fiber atrophy (HP:0100295) | 2.11657163 |
| 83 | Nasal polyposis (HP:0100582) | 2.11581980 |
| 84 | Nonimmune hydrops fetalis (HP:0001790) | 2.11024709 |
| 85 | Increased intramyocellular lipid droplets (HP:0012240) | 2.08317338 |
| 86 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.08294102 |
| 87 | Single umbilical artery (HP:0001195) | 2.08294102 |
| 88 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.08294102 |
| 89 | Increased serum pyruvate (HP:0003542) | 2.08226110 |
| 90 | Abnormality of glycolysis (HP:0004366) | 2.08226110 |
| 91 | Abnormal neuron morphology (HP:0012757) | 2.06990064 |
| 92 | Abnormality of the motor neurons (HP:0002450) | 2.06990064 |
| 93 | Opisthotonus (HP:0002179) | 2.06871749 |
| 94 | Lactic acidosis (HP:0003128) | 2.05033406 |
| 95 | Abnormal trabecular bone morphology (HP:0100671) | 2.04724276 |
| 96 | Cutaneous melanoma (HP:0012056) | 2.04057526 |
| 97 | Increased CSF lactate (HP:0002490) | 2.03815553 |
| 98 | Hepatosplenomegaly (HP:0001433) | 2.03331177 |
| 99 | 3-Methylglutaconic aciduria (HP:0003535) | 2.02528124 |
| 100 | Exertional dyspnea (HP:0002875) | 2.01903147 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 2.01700356 |
| 102 | Recurrent abscess formation (HP:0002722) | 2.01638043 |
| 103 | Nausea (HP:0002018) | 2.01300151 |
| 104 | Hypoplasia of the thymus (HP:0000778) | 2.00981592 |
| 105 | IgG deficiency (HP:0004315) | 2.00911124 |
| 106 | Selective tooth agenesis (HP:0001592) | 1.99671011 |
| 107 | Sparse eyelashes (HP:0000653) | 1.96483256 |
| 108 | White forelock (HP:0002211) | 1.95738943 |
| 109 | Secondary amenorrhea (HP:0000869) | 1.95512733 |
| 110 | Hand muscle atrophy (HP:0009130) | 1.95503920 |
| 111 | Progressive muscle weakness (HP:0003323) | 1.94683683 |
| 112 | Hypertensive crisis (HP:0100735) | 1.94488980 |
| 113 | Abnormality of the gallbladder (HP:0005264) | 1.94249182 |
| 114 | Respiratory difficulties (HP:0002880) | 1.94169195 |
| 115 | Pancytopenia (HP:0001876) | 1.93831073 |
| 116 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.93549292 |
| 117 | Biconcave vertebral bodies (HP:0004586) | 1.93489921 |
| 118 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.92725743 |
| 119 | Dicarboxylic aciduria (HP:0003215) | 1.92725743 |
| 120 | J-shaped sella turcica (HP:0002680) | 1.92159697 |
| 121 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.91884838 |
| 122 | Protrusio acetabuli (HP:0003179) | 1.91792648 |
| 123 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.91700557 |
| 124 | Pallor (HP:0000980) | 1.91686963 |
| 125 | Distal lower limb muscle weakness (HP:0009053) | 1.90599600 |
| 126 | Abnormality of the nasal mucosa (HP:0000433) | 1.90592707 |
| 127 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.89824116 |
| 128 | Abnormality of alanine metabolism (HP:0010916) | 1.89824116 |
| 129 | Hyperalaninemia (HP:0003348) | 1.89824116 |
| 130 | Methylmalonic aciduria (HP:0012120) | 1.89731529 |
| 131 | Delusions (HP:0000746) | 1.89280367 |
| 132 | CNS hypomyelination (HP:0003429) | 1.88688136 |
| 133 | Progressive neurologic deterioration (HP:0002344) | 1.86615652 |
| 134 | Paraparesis (HP:0002385) | 1.85034422 |
| 135 | Abnormality of eosinophils (HP:0001879) | 1.85003671 |
| 136 | Upper limb amyotrophy (HP:0009129) | 1.84916226 |
| 137 | Distal upper limb amyotrophy (HP:0007149) | 1.84916226 |
| 138 | Lethargy (HP:0001254) | 1.84391529 |
| 139 | Abnormality of T cell physiology (HP:0011840) | 1.84222962 |
| 140 | Ragged-red muscle fibers (HP:0003200) | 1.84103600 |
| 141 | Fasciculations (HP:0002380) | 1.83450728 |
| 142 | Muscle fibrillation (HP:0010546) | 1.83047083 |
| 143 | Tongue fasciculations (HP:0001308) | 1.82376116 |
| 144 | Type 2 muscle fiber atrophy (HP:0003554) | 1.82330755 |
| 145 | Premature graying of hair (HP:0002216) | 1.81948098 |
| 146 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.81051137 |
| 147 | Generalized aminoaciduria (HP:0002909) | 1.80707468 |
| 148 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.80679786 |
| 149 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.80679786 |
| 150 | Abnormality of glycolipid metabolism (HP:0010969) | 1.80679786 |
| 151 | Dysostosis multiplex (HP:0000943) | 1.80656904 |
| 152 | Lymphopenia (HP:0001888) | 1.79558644 |
| 153 | Lymphoma (HP:0002665) | 1.78130327 |
| 154 | Personality changes (HP:0000751) | 1.77818827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 3.86005368 |
| 2 | VRK2 | 3.76057859 |
| 3 | KDR | 3.66229553 |
| 4 | NME2 | 3.42214303 |
| 5 | TESK2 | 3.40647174 |
| 6 | STK16 | 3.05295816 |
| 7 | MAP4K1 | 2.95866486 |
| 8 | PIM2 | 2.80027782 |
| 9 | EIF2AK1 | 2.60825814 |
| 10 | ERN1 | 2.50578228 |
| 11 | WEE1 | 2.37308087 |
| 12 | ZAP70 | 2.21493363 |
| 13 | BCKDK | 2.18936777 |
| 14 | MAP3K11 | 1.95278326 |
| 15 | EIF2AK3 | 1.88742609 |
| 16 | TESK1 | 1.79727252 |
| 17 | TXK | 1.78185784 |
| 18 | PDK2 | 1.70255597 |
| 19 | CDC7 | 1.65187104 |
| 20 | SCYL2 | 1.63326132 |
| 21 | MAPKAPK3 | 1.56579663 |
| 22 | PBK | 1.53502865 |
| 23 | LRRK2 | 1.50842300 |
| 24 | BLK | 1.42940964 |
| 25 | STK10 | 1.42577775 |
| 26 | ARAF | 1.41809304 |
| 27 | RPS6KA4 | 1.41216815 |
| 28 | ACVR1B | 1.35024355 |
| 29 | LIMK1 | 1.32513097 |
| 30 | TYK2 | 1.32088340 |
| 31 | SRPK1 | 1.29419469 |
| 32 | TSSK6 | 1.28051776 |
| 33 | TRIB3 | 1.25104211 |
| 34 | TBK1 | 1.24288880 |
| 35 | JAK3 | 1.16090995 |
| 36 | LMTK2 | 1.16048887 |
| 37 | SMG1 | 1.13718505 |
| 38 | PAK4 | 1.11532020 |
| 39 | EPHA2 | 1.08907560 |
| 40 | VRK1 | 1.07906735 |
| 41 | TRIM28 | 1.06660299 |
| 42 | RPS6KB2 | 1.06656867 |
| 43 | CDK7 | 1.06058068 |
| 44 | CSNK1A1L | 1.05918035 |
| 45 | BTK | 1.04570308 |
| 46 | NEK1 | 1.03306046 |
| 47 | MAP2K3 | 0.97977048 |
| 48 | GRK6 | 0.97254802 |
| 49 | MAP3K12 | 0.94692175 |
| 50 | IKBKE | 0.92340313 |
| 51 | FGFR4 | 0.90968774 |
| 52 | NEK2 | 0.90388468 |
| 53 | PKN2 | 0.88923557 |
| 54 | MAP3K8 | 0.88878713 |
| 55 | IRAK4 | 0.88278814 |
| 56 | AURKA | 0.87686176 |
| 57 | MST1R | 0.86803718 |
| 58 | PIM1 | 0.86130762 |
| 59 | ILK | 0.85290652 |
| 60 | CSNK1G1 | 0.83803978 |
| 61 | CCNB1 | 0.83230363 |
| 62 | SIK1 | 0.83167171 |
| 63 | KIT | 0.82919125 |
| 64 | TIE1 | 0.82883515 |
| 65 | EEF2K | 0.82777764 |
| 66 | MYLK | 0.80992816 |
| 67 | DAPK1 | 0.80691769 |
| 68 | CDK4 | 0.80559753 |
| 69 | DAPK3 | 0.80472438 |
| 70 | ABL2 | 0.80344270 |
| 71 | PLK1 | 0.79665237 |
| 72 | ITK | 0.79056422 |
| 73 | CSNK1G2 | 0.74993829 |
| 74 | PAK1 | 0.74251268 |
| 75 | BRSK2 | 0.73399506 |
| 76 | DYRK3 | 0.72348236 |
| 77 | CDK8 | 0.72089408 |
| 78 | ICK | 0.71404567 |
| 79 | TGFBR1 | 0.68193086 |
| 80 | FLT3 | 0.68116576 |
| 81 | TAOK2 | 0.67256490 |
| 82 | NLK | 0.67226153 |
| 83 | LCK | 0.66998274 |
| 84 | TAOK1 | 0.66478231 |
| 85 | MST4 | 0.66202128 |
| 86 | TEC | 0.66195298 |
| 87 | CDK19 | 0.65821960 |
| 88 | AURKB | 0.65566705 |
| 89 | PLK4 | 0.65404782 |
| 90 | SYK | 0.64537423 |
| 91 | IRAK3 | 0.63612465 |
| 92 | SIK3 | 0.63175520 |
| 93 | NME1 | 0.61695138 |
| 94 | TLK1 | 0.60331916 |
| 95 | PTK2 | 0.56294738 |
| 96 | BRAF | 0.55854351 |
| 97 | MARK3 | 0.54137037 |
| 98 | GRK7 | 0.53610108 |
| 99 | ATR | 0.53175431 |
| 100 | MAP3K3 | 0.52710432 |
| 101 | PHKG1 | 0.52503945 |
| 102 | PHKG2 | 0.52503945 |
| 103 | MAP3K5 | 0.50759680 |
| 104 | LYN | 0.49429829 |
| 105 | CSNK2A2 | 0.49382256 |
| 106 | MAP4K2 | 0.49152096 |
| 107 | TTK | 0.48715576 |
| 108 | RAF1 | 0.48286951 |
| 109 | MAPK11 | 0.46781907 |
| 110 | IKBKB | 0.46619726 |
| 111 | CAMK2G | 0.46322368 |
| 112 | BRSK1 | 0.46061447 |
| 113 | CSNK2A1 | 0.45225600 |
| 114 | MAPKAPK5 | 0.44632726 |
| 115 | PRKCI | 0.44520238 |
| 116 | MAP3K10 | 0.44416099 |
| 117 | PASK | 0.41771572 |
| 118 | ERBB4 | 0.41642262 |
| 119 | AKT2 | 0.40301158 |
| 120 | GRK5 | 0.39195970 |
| 121 | IRAK2 | 0.38383379 |
| 122 | MUSK | 0.38067108 |
| 123 | PRKD2 | 0.38043251 |
| 124 | PRKD3 | 0.37807986 |
| 125 | MAPKAPK2 | 0.37493459 |
| 126 | CHEK2 | 0.37294458 |
| 127 | CAMK2D | 0.36924274 |
| 128 | CDK14 | 0.34591552 |
| 129 | CSK | 0.33916382 |
| 130 | CLK1 | 0.33554734 |
| 131 | CSNK1G3 | 0.32700937 |
| 132 | PRKCD | 0.31969366 |
| 133 | RPS6KA6 | 0.31579582 |
| 134 | PIK3CG | 0.31168395 |
| 135 | RPS6KA5 | 0.30769416 |
| 136 | DYRK2 | 0.30585298 |
| 137 | NUAK1 | 0.29876105 |
| 138 | PRKD1 | 0.29851349 |
| 139 | CDK9 | 0.28796424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.48870510 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.82493161 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.68012763 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 2.94394407 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.81530919 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.52685751 |
| 7 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.32882810 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.28255191 |
| 9 | Spliceosome_Homo sapiens_hsa03040 | 2.27198100 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.12484683 |
| 11 | RNA transport_Homo sapiens_hsa03013 | 1.94659805 |
| 12 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.89706591 |
| 13 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.86856031 |
| 14 | Sulfur relay system_Homo sapiens_hsa04122 | 1.79228492 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.73813024 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.70159262 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.60400500 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.57651877 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.55129230 |
| 20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.52127214 |
| 21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.49227786 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.48720137 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.47009937 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46384505 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38947944 |
| 26 | Cell cycle_Homo sapiens_hsa04110 | 1.37469072 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34526846 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.29469496 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29144994 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25821470 |
| 31 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.24381938 |
| 32 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.20906689 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.20278133 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.17675124 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.16332013 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13956496 |
| 37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.13405702 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.11565329 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.04646149 |
| 40 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.03535314 |
| 41 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03459110 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00387661 |
| 43 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96304353 |
| 44 | Purine metabolism_Homo sapiens_hsa00230 | 0.95703550 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 0.92096982 |
| 46 | Basal transcription factors_Homo sapiens_hsa03022 | 0.90029901 |
| 47 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89781353 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.88544489 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 0.88322577 |
| 50 | RNA degradation_Homo sapiens_hsa03018 | 0.87175208 |
| 51 | Huntingtons disease_Homo sapiens_hsa05016 | 0.84499421 |
| 52 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.83613406 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83469801 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.80520722 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80503020 |
| 56 | Measles_Homo sapiens_hsa05162 | 0.80419961 |
| 57 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.78829607 |
| 58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78661373 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78433822 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78411737 |
| 61 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.73989205 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.72881685 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.72261747 |
| 64 | Allograft rejection_Homo sapiens_hsa05330 | 0.70687931 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.70034228 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.68769991 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66954617 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65062527 |
| 69 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64086086 |
| 70 | Leishmaniasis_Homo sapiens_hsa05140 | 0.64037486 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64021365 |
| 72 | Asthma_Homo sapiens_hsa05310 | 0.62225328 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.61331436 |
| 74 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.60490890 |
| 75 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60364158 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60094014 |
| 77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57794414 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57626639 |
| 79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57268301 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.56488665 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56400454 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54949436 |
| 83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54727202 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53768444 |
| 85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53585728 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53423731 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53159169 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.53111243 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52543020 |
| 90 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.50946684 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49668949 |
| 92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49644090 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.49511985 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47746799 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.46401047 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45143872 |
| 97 | Alzheimers disease_Homo sapiens_hsa05010 | 0.44633395 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44043466 |
| 99 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.43616108 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43272943 |
| 101 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.41835785 |
| 102 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.41241244 |
| 103 | Salmonella infection_Homo sapiens_hsa05132 | 0.40260729 |
| 104 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.40065931 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38121056 |
| 106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37712807 |
| 107 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.37621137 |
| 108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37375539 |
| 109 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.36787476 |
| 110 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.36091900 |
| 111 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34806206 |
| 112 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.34076759 |
| 113 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.33849810 |
| 114 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.32498584 |
| 115 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32030957 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31450024 |
| 117 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.28886188 |
| 118 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.28443656 |
| 119 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.27839597 |
| 120 | Hepatitis B_Homo sapiens_hsa05161 | 0.26334643 |
| 121 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.25677644 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.24548968 |

